Skip to Main Content

Author Archives: O’Neill Institute

10.20.20

Leading the COVID-19 Vaccination Response: Lessons Learned from the Smallpox Eradication Campaign

By O’Neill Institute

This expert column was written by Adi Radhakrishnan.  With more than 40 million known cases worldwide, and many countries already experiencing a second surge, the global recovery from COVID-19 still appears far away. Experts recently forecast that that the full course of the pandemic will likely run for two years and will only subside if […]

Tags:

10.01.20

COVID-19 Global Action Plan Letter

By O’Neill Institute

The global response to the COVID-19 pandemic has been marked by a tragic lack of global solidarity, with several exceptions, notably COVAX, a global facility for equitable vaccine distribution. Dozens of global health leaders have therefore joined together to call upon a number of current presidents and prime ministers, The Elders, and the Champions for an AIDS-Free Generation to spearhead a […]

Tags:
Thematic Areas: Health & Human Rights

09.01.20

Big Soda Sanctioned for Deceptive Advertising in Landmark Decision in Colombia

By O’Neill Institute

This expert column was written by Isabel Barbosa and Ariadna Tovar Ramírez.  On July 10, 2020, the national authority on consumer protection in Colombia (Superintendencia de Industria y Comercio, or SIC) imposed a fine of approximately US$500,000 on Postobón, the biggest soda company in the country. The decision found that Postobón’s deceptive advertising of the […]

Categories:
Tags:

08.20.20

Q&A with Kashish Aneja

By O’Neill Institute

Kashish Aneja is a practicing lawyer in New Delhi, and an international legal consultant specializing in Global Health Law. Currently, he’s consulting for the O’Neill Institute, and over the past 2 years, he worked in different capacities for the World Health Organization (WHO), Centre for Reproductive Rights and GAVI the Vaccine Alliance. 1. What drew […]

Tags:

08.11.20

Medication-Based Treatment for Substance Use Disorder in Correctional Facilities: 2020 State Legislation & the Long Road to Providing Treatment to Incarcerated Populations

By O’Neill Institute

This post was written by Kristin D. Ewing.  Over 20 million people reported having a substance use disorder in 2018, including alcohol use disorders and opioid use disorders. As the science continues to shift on best practices for substance use disorder treatment, there has been a huge push to increase access to treatment and recovery […]

Tags:
Thematic Areas: Addiction & Public Policy

08.06.20

The Final Say on Australia’s Plain Packaging Law at the WTO

By O’Neill Institute

This post was written by Nicholas J. Diamond, JD, LLM, MBe, an Adjunct Professor of Law at Georgetown Law. His academic work focuses on the intersection of economic issues, human rights, and the law. On June 9, the World Trade Organization (WTO) disputes concerning Australia’s plain packaging law for tobacco products, which began in 2012, […]

Tags:

07.28.20

Who Bears the Burden?: How Current HCV Elimination Efforts Are Likely to Exacerbate the Existing HCV Burden on Vulnerable LGBT and Immigrant Populations

By O’Neill Institute

This article was written by Prashasti Bhatnagar, JD/MPH candidate at Georgetown University Law Center/Johns Hopkins Bloomberg School of Public Health. INTRODUCTION Hepatitis C is one of the most common blood-borne infections in the United States; about 3.5 million persons are estimated to be chronically infected with hepatitis C virus (HCV) infections in the nation. Health […]

Thematic Areas: Infectious Diseases

07.28.20

UN Experts Call for Decisive Measures to Tackle NCDs: Front-of-Package Warning Labelling

By O’Neill Institute

This blog post was written by Oscar A. Cabrera and Andrés Constantin. “Without clear efforts to promote action on the prevention of unhealthy diets, the rise of [noncommunicable diseases] will remain on the margins of global health action. States cannot remain passive in the face of NCDs. They should adopt an integral approach to reduce […]

Tags:

07.13.20

The Impact of the Telehealth Response for E-Prescribing Addiction Therapy Services (“TREATS”) Act

By O’Neill Institute

This blog post was written by Landon Myers. Four months after the United States began to feel the effects of COVID-19, U.S. Senators Rob Portman (R-OH) and Sheldon Whitehouse (D-RI) introduced the Telehealth Response for E-Prescribing Addiction Therapy Services (“TREATS”) Act. During the pandemic, policymakers and insurers have strongly embraced telehealth, or the remote provision […]

Tags:

07.10.20

How the WHO Provides Unique Value in an Epidemic Crisis

By O’Neill Institute

This blog post was written by Adi Radhakrishnan. Main Point: Current critiques of the World Health Organization fail to appreciate its formal structure as a member state-based institution, its practical constraints in acting as a supranational authority, and the enduring value of its legitimacy in sharing normative technical information in a crisis. As the COVID-19 […]

Categories:
Tags:

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.